Related Experiment Video
Updated: Jun 13, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.2K
Culturally adapted mobile application for optimizing metabolic control in type 1 diabetes: a pilot study
Jenny L Cepeda-Marte1, Arelis Moore2, Carlos B Ruiz-Matuk1
1Universidad Iberoamericana Research Hub Santo Domingo Dominican Republic Universidad Iberoamericana, Research Hub, Santo Domingo, Dominican Republic.
Summary
A mobile app, culturally adapted for adolescents with type 1 diabetes, significantly improved lipid profiles and quality of life. This digital tool aids in better metabolic health management for young patients.
Area of Science:
- Pediatric Endocrinology
- Digital Health Interventions
- Metabolic Syndrome Management
Background:
- Adolescents with type 1 diabetes require continuous management for metabolic control.
- Culturally relevant tools can enhance engagement and adherence to treatment plans.
- Mobile applications offer a scalable platform for delivering health education and support.
Purpose of the Study:
- To assess the impact of a culturally adapted mobile application on metabolic control in adolescents with type 1 diabetes.
- To evaluate changes in lipid profiles and quality of life among study participants.
- To determine the effectiveness of a culturally tailored app in supporting diabetes self-management.
Main Methods:
- A 3-month study involving 23 pediatric participants with type 1 diabetes.
- Utilized a mobile app with a bolus insulin calculator and culturally specific food lists with glycemic index (GI) color-coding.
- Blood tests were conducted pre- and post-intervention to monitor metabolic markers.
Main Results:
- Statistically significant improvements were observed in lipid profiles, with HDL levels increasing and LDL and triglyceride levels decreasing.
- Participants reported an overall increase in quality of life.
- No statistically significant changes were noted in glycated hemoglobin levels.
Conclusions:
- The culturally tailored mobile app demonstrated potential in improving metabolic health markers among adolescents with type 1 diabetes.
- The app's features, including culturally relevant food information and a bolus calculator, may contribute to better dietary choices and insulin management.
- Further research is warranted to explore the long-term impact on glycemic control and broader health outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:16Insulin: Dosing Regimen and Adverse Effects
157
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
157
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183